Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025

Page 3 of 14

12. BeiGene Ltd. (NASDAQ:ONC)

Number of Hedge Fund Holders In Q4 2024: 30

BeiGene Ltd. (NASDAQ:ONC) is a company that makes cancer treatments.

The stock is up significantly so far in 2025 after solid Q4 and full-year results.

It reported global revenue growth of 78% year-over-year to $1.1 billion in Q4 2024. Full-year revenue grew 55% to $3.8 billion.

The company also guided for $4.9-5.3 billion in 2025 revenue and exceeded Wall Street’s expectations of $4.74 billion. It also anticipates positive GAAP operating income and cash flow.

ONC is up 50.71% year-to-date.

Page 3 of 14